Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Repellin

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 30, 2026
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacyMathieu Repellin, Stefano Ugel, Francesco De Sanctis, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2025
Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophyIlaria Andreana, Ananga Ghosh, Mathieu Repellin, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 30, 2026
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacyMathieu Repellin, Stefano Ugel, Francesco De Sanctis, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2025
Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophyIlaria Andreana, Ananga Ghosh, Mathieu Repellin, et al.
Pageof 2